Clascoterone
also Breezula, CB-03-01, Winlevi
Clascoterone, sold under the brand name Winlevi, is an antiandrogen medication which is used topically in the treatment of acne. The medication is used as a cream by application to the skin, for instance the face and scalp. Clascoterone is an antiandrogen, or antagonist of the androgen receptor (AR), the biological target of androgens such as testosterone and dihydrotestosterone. It shows minimal systemic absorption when applied to skin.
Read “Clascoterone” on Wikipedia and its adverse effects · text from Wikipedia, CC BY-SA 4.0
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 10
- 0951 Breezula, a clinical stage topical anti-androgen, promotes dermal papilla inductivity and reduces IL-6 secretion in balding skin samples ex vivo
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Living Probiotic Microneedles Coordinate Antiandrogen and Nitric Oxide Therapy for Androgenetic Alopecia
- Clascoterone: First Approval
- Cortexolone 17a-propionate: A new antiandrogen acting on hair dermal papilla cells for the treatment of androgenic alopecia
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- Differential diagnosis of trichotillomania by trichoscopy
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Androgenetic alopecia: An update
- Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments
Community 10
- Clascoterone Phase 3 Results and Efficacy
- I Get Side-Effects from Anti-Androgens
- Why isn’t Clascoterone being discussed more?
- What has the evidence been on side effects with CB?
- Winlevi Clascoterone- resultssss
- M20 with Hair Loss - Clascoterone an Option?
- Whatever happened to Clascoterone? (breezula for hair) (sold as Winlevi for acne available since 2021)
- Has anyone tried CB-01-03 aka Clascoterone?
- Clascoterone full results 2026
- Why is everyone still arguing about PP405 when clascoterone is already heading toward regulatory submission?